- A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin(R) in Patients with Type 1 Gaucher Disease
-
Choi JH, Lee BH, Ko JM, Sohn YB, Lee JS, Kim GH, Heo SH, Park JY, Kim YM, Kim JH, Yoo HW
- KMID: 2164444
- J Korean Med Sci.
- 2015 Apr;30(4):378-384.
- doi: 10.3346/jkms.2015.30.4.378
Gaucher disease is a lysosomal storage disease for which enzyme replacement therapy has proven to be effective. A switch-over clinical trial was performed to evaluate the efficacy and safety of... -
- CITED
-
- Close
- SHARE
-
- Close
